Car T Cell Immunotherapy Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0077784
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:8.64
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 8.64 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient's blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as "living drugs" and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.In 2018, the global CAR T-Cell Immunotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.
This report focuses on the global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Immunotherapy development in United States, Europe and China.
The key players covered in this study
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Market segment by Type, the product can be split into
Monotherapy
Combination Therapy
Market segment by Application, split into
Hematologic Malignancies
Solid Malignancies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players.
To present the CAR T-Cell Immunotherapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of CAR T-Cell Immunotherapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application (2014-2025)
1.5.2 Hematologic Malignancies
1.5.3 Solid Malignancies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 CAR T-Cell Immunotherapy Market Size
2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
2.2.1 CAR T-Cell Immunotherapy Market Size by Regions (2014-2025)
2.2.2 CAR T-Cell Immunotherapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 CAR T-Cell Immunotherapy Market Size by Manufacturers
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Manufacturers (2014-2019)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.3 Key Players CAR T-Cell Immunotherapy Product/Solution/Service
3.4 Date of Enter into CAR T-Cell Immunotherapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global CAR T-Cell Immunotherapy Market Size by Type (2014-2019)
4.2 Global CAR T-Cell Immunotherapy Market Size by Application (2014-2019)
5 United States
5.1 United States CAR T-Cell Immunotherapy Market Size (2014-2019)
5.2 CAR T-Cell Immunotherapy Key Players in United States
5.3 United States CAR T-Cell Immunotherapy Market Size by Type
5.4 United States CAR T-Cell Immunotherapy Market Size by Application
6 Europe
6.1 Europe CAR T-Cell Immunotherapy Market Size (2014-2019)
6.2 CAR T-Cell Immunotherapy Key Players in Europe
6.3 Europe CAR T-Cell Immunotherapy Market Size by Type
6.4 Europe CAR T-Cell Immunotherapy Market Size by Application
7 China
7.1 China CAR T-Cell Immunotherapy Market Size (2014-2019)
7.2 CAR T-Cell Immunotherapy Key Players in China
7.3 China CAR T-Cell Immunotherapy Market Size by Type
7.4 China CAR T-Cell Immunotherapy Market Size by Application
8 Japan
8.1 Japan CAR T-Cell Immunotherapy Market Size (2014-2019)
8.2 CAR T-Cell Immunotherapy Key Players in Japan
8.3 Japan CAR T-Cell Immunotherapy Market Size by Type
8.4 Japan CAR T-Cell Immunotherapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2014-2019)
9.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia
9.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type
9.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application
10 India
10.1 India CAR T-Cell Immunotherapy Market Size (2014-2019)
10.2 CAR T-Cell Immunotherapy Key Players in India
10.3 India CAR T-Cell Immunotherapy Market Size by Type
10.4 India CAR T-Cell Immunotherapy Market Size by Application
11 Central & South America
11.1 Central & South America CAR T-Cell Immunotherapy Market Size (2014-2019)
11.2 CAR T-Cell Immunotherapy Key Players in Central & South America
11.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type
11.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application
12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 CAR T-Cell Immunotherapy Introduction
12.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Celgene
12.2.1 Celgene Company Details
12.2.2 Company Description and Business Overview
12.2.3 CAR T-Cell Immunotherapy Introduction
12.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.2.5 Celgene Recent Development
12.3 Kite Pharma
12.3.1 Kite Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 CAR T-Cell Immunotherapy Introduction
12.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.3.5 Kite Pharma Recent Development
12.4 Oxford BioMedica
12.4.1 Oxford BioMedica Company Details
12.4.2 Company Description and Business Overview
12.4.3 CAR T-Cell Immunotherapy Introduction
12.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.4.5 Oxford BioMedica Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 CAR T-Cell Immunotherapy Introduction
12.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Gilead
12.6.1 Gilead Company Details
12.6.2 Company Description and Business Overview
12.6.3 CAR T-Cell Immunotherapy Introduction
12.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.6.5 Gilead Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 CAR T-Cell Immunotherapy Introduction
12.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Cellectis
12.8.1 Cellectis Company Details
12.8.2 Company Description and Business Overview
12.8.3 CAR T-Cell Immunotherapy Introduction
12.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.8.5 Cellectis Recent Development
12.9 Bellicum
12.9.1 Bellicum Company Details
12.9.2 Company Description and Business Overview
12.9.3 CAR T-Cell Immunotherapy Introduction
12.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.9.5 Bellicum Recent Development
12.10 Mustang Bio
12.10.1 Mustang Bio Company Details
12.10.2 Company Description and Business Overview
12.10.3 CAR T-Cell Immunotherapy Introduction
12.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.10.5 Mustang Bio Recent Development
12.11 CARsgen Therapeutics
12.12 Xyphos
12.13 Minerva Biotechnologies
12.14 Adaptimmune
12.15 Ziopharm Oncology
12.16 Aurora Biopharma
12.17 Creative Biolabs
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table CAR T-Cell Immunotherapy Key Market Segments
Table Key Players CAR T-Cell Immunotherapy Covered
Table Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Combination Therapy Figures
Table Key Players of Combination Therapy
Table Global CAR T-Cell Immunotherapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hematologic Malignancies Case Studies
Figure Solid Malignancies Case Studies
Figure CAR T-Cell Immunotherapy Report Years Considered
Table Global CAR T-Cell Immunotherapy Market Size 2014-2025 (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size by Regions 2014-2025 (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size by Regions 2014-2019 (Million US$)
Table Global CAR T-Cell Immunotherapy Market Share by Regions 2014-2019
Figure Global CAR T-Cell Immunotherapy Market Share by Regions 2014-2019
Figure Global CAR T-Cell Immunotherapy Market Share by Regions 2019
Table Market Top Trends
Table Global CAR T-Cell Immunotherapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global CAR T-Cell Immunotherapy Market Share by Manufacturers (2014-2019)
Figure Global CAR T-Cell Immunotherapy Market Share by Manufacturers in 2018
Table Global CAR T-Cell Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players CAR T-Cell Immunotherapy Product/Solution/Service
Table Date of Enter into CAR T-Cell Immunotherapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size Share by Type (2014-2019)
Figure Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2014-2019)
Table Global CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size Share by Application (2014-2019)
Figure Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Application in 2018
Figure United States CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table United States Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table United States Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table United States CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table United States CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table United States CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table United States CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Europe CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Europe Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Europe Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Europe CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Europe CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Europe CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Europe CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure China CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table China Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table China Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table China CAR T-Cell Immunotherapy Market Size by Type (2014-20189) (Million US$)
Table China CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table China CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table China CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Japan CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Japan Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Japan Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Japan CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Japan CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Japan CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Japan CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Southeast Asia CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure India CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table India Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table India Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table India CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table India CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table India CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table India CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Central & South America CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Central & South America CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Central & South America CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in CAR T-Cell Immunotherapy Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table AbbVie Recent Development
Table Celgene Company Details
Table Celgene Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Celgene Recent Development
Table Kite Pharma Company Details
Table Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Kite Pharma Recent Development
Table Oxford BioMedica Company Details
Table Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Oxford BioMedica Recent Development
Table Novartis Company Details
Table Novartis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Novartis Recent Development
Table Gilead Company Details
Table Gilead Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Gilead Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Pfizer Recent Development
Table Cellectis Company Details
Table Cellectis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Cellectis Recent Development
Table Bellicum Company Details
Table Bellicum Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Bellicum Recent Development
Table Mustang Bio Company Details
Table Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Mustang Bio Recent Development
Table CARsgen Therapeutics Company Details
Table Xyphos Company Details
Table Minerva Biotechnologies Company Details
Table Adaptimmune Company Details
Table Ziopharm Oncology Company Details
Table Aurora Biopharma Company Details
Table Creative Biolabs Company Details
Table Global CAR T-Cell Immunotherapy Market Size by Regions (Million US$) 2019-2025
Figure Global CAR T-Cell Immunotherapy Market Size Share by Regions (2019-2025)
Figure Global CAR T-Cell Immunotherapy Market Size Share by Regions in 2025
Figure United States CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure China CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure India CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Table Global CAR T-Cell Immunotherapy Market Size by Product (2019-2025) (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size by Product (2019-2025)
Figure Global CAR T-Cell Immunotherapy Market Size by Product in 2025
Table Global CAR T-Cell Immunotherapy Market Size by Application (2019-2025) (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size by Application (2019-2025)
Figure Global CAR T-Cell Immunotherapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application (2014-2025)
1.5.2 Hematologic Malignancies
1.5.3 Solid Malignancies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 CAR T-Cell Immunotherapy Market Size
2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
2.2.1 CAR T-Cell Immunotherapy Market Size by Regions (2014-2025)
2.2.2 CAR T-Cell Immunotherapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 CAR T-Cell Immunotherapy Market Size by Manufacturers
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Manufacturers (2014-2019)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.3 Key Players CAR T-Cell Immunotherapy Product/Solution/Service
3.4 Date of Enter into CAR T-Cell Immunotherapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global CAR T-Cell Immunotherapy Market Size by Type (2014-2019)
4.2 Global CAR T-Cell Immunotherapy Market Size by Application (2014-2019)
5 United States
5.1 United States CAR T-Cell Immunotherapy Market Size (2014-2019)
5.2 CAR T-Cell Immunotherapy Key Players in United States
5.3 United States CAR T-Cell Immunotherapy Market Size by Type
5.4 United States CAR T-Cell Immunotherapy Market Size by Application
6 Europe
6.1 Europe CAR T-Cell Immunotherapy Market Size (2014-2019)
6.2 CAR T-Cell Immunotherapy Key Players in Europe
6.3 Europe CAR T-Cell Immunotherapy Market Size by Type
6.4 Europe CAR T-Cell Immunotherapy Market Size by Application
7 China
7.1 China CAR T-Cell Immunotherapy Market Size (2014-2019)
7.2 CAR T-Cell Immunotherapy Key Players in China
7.3 China CAR T-Cell Immunotherapy Market Size by Type
7.4 China CAR T-Cell Immunotherapy Market Size by Application
8 Japan
8.1 Japan CAR T-Cell Immunotherapy Market Size (2014-2019)
8.2 CAR T-Cell Immunotherapy Key Players in Japan
8.3 Japan CAR T-Cell Immunotherapy Market Size by Type
8.4 Japan CAR T-Cell Immunotherapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2014-2019)
9.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia
9.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type
9.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application
10 India
10.1 India CAR T-Cell Immunotherapy Market Size (2014-2019)
10.2 CAR T-Cell Immunotherapy Key Players in India
10.3 India CAR T-Cell Immunotherapy Market Size by Type
10.4 India CAR T-Cell Immunotherapy Market Size by Application
11 Central & South America
11.1 Central & South America CAR T-Cell Immunotherapy Market Size (2014-2019)
11.2 CAR T-Cell Immunotherapy Key Players in Central & South America
11.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type
11.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application
12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 CAR T-Cell Immunotherapy Introduction
12.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Celgene
12.2.1 Celgene Company Details
12.2.2 Company Description and Business Overview
12.2.3 CAR T-Cell Immunotherapy Introduction
12.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.2.5 Celgene Recent Development
12.3 Kite Pharma
12.3.1 Kite Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 CAR T-Cell Immunotherapy Introduction
12.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.3.5 Kite Pharma Recent Development
12.4 Oxford BioMedica
12.4.1 Oxford BioMedica Company Details
12.4.2 Company Description and Business Overview
12.4.3 CAR T-Cell Immunotherapy Introduction
12.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.4.5 Oxford BioMedica Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 CAR T-Cell Immunotherapy Introduction
12.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Gilead
12.6.1 Gilead Company Details
12.6.2 Company Description and Business Overview
12.6.3 CAR T-Cell Immunotherapy Introduction
12.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.6.5 Gilead Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 CAR T-Cell Immunotherapy Introduction
12.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Cellectis
12.8.1 Cellectis Company Details
12.8.2 Company Description and Business Overview
12.8.3 CAR T-Cell Immunotherapy Introduction
12.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.8.5 Cellectis Recent Development
12.9 Bellicum
12.9.1 Bellicum Company Details
12.9.2 Company Description and Business Overview
12.9.3 CAR T-Cell Immunotherapy Introduction
12.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.9.5 Bellicum Recent Development
12.10 Mustang Bio
12.10.1 Mustang Bio Company Details
12.10.2 Company Description and Business Overview
12.10.3 CAR T-Cell Immunotherapy Introduction
12.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
12.10.5 Mustang Bio Recent Development
12.11 CARsgen Therapeutics
12.12 Xyphos
12.13 Minerva Biotechnologies
12.14 Adaptimmune
12.15 Ziopharm Oncology
12.16 Aurora Biopharma
12.17 Creative Biolabs
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table CAR T-Cell Immunotherapy Key Market Segments
Table Key Players CAR T-Cell Immunotherapy Covered
Table Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Combination Therapy Figures
Table Key Players of Combination Therapy
Table Global CAR T-Cell Immunotherapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hematologic Malignancies Case Studies
Figure Solid Malignancies Case Studies
Figure CAR T-Cell Immunotherapy Report Years Considered
Table Global CAR T-Cell Immunotherapy Market Size 2014-2025 (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size by Regions 2014-2025 (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size by Regions 2014-2019 (Million US$)
Table Global CAR T-Cell Immunotherapy Market Share by Regions 2014-2019
Figure Global CAR T-Cell Immunotherapy Market Share by Regions 2014-2019
Figure Global CAR T-Cell Immunotherapy Market Share by Regions 2019
Table Market Top Trends
Table Global CAR T-Cell Immunotherapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global CAR T-Cell Immunotherapy Market Share by Manufacturers (2014-2019)
Figure Global CAR T-Cell Immunotherapy Market Share by Manufacturers in 2018
Table Global CAR T-Cell Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players CAR T-Cell Immunotherapy Product/Solution/Service
Table Date of Enter into CAR T-Cell Immunotherapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size Share by Type (2014-2019)
Figure Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2014-2019)
Table Global CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Global CAR T-Cell Immunotherapy Market Size Share by Application (2014-2019)
Figure Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Application in 2018
Figure United States CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table United States Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table United States Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table United States CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table United States CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table United States CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table United States CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Europe CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Europe Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Europe Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Europe CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Europe CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Europe CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Europe CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure China CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table China Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table China Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table China CAR T-Cell Immunotherapy Market Size by Type (2014-20189) (Million US$)
Table China CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table China CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table China CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Japan CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Japan Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Japan Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Japan CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Japan CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Japan CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Japan CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Southeast Asia CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure India CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table India Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table India Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table India CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table India CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table India CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table India CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Central & South America CAR T-Cell Immunotherapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players CAR T-Cell Immunotherapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players CAR T-Cell Immunotherapy Market Share (2018-2019)
Table Central & South America CAR T-Cell Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Immunotherapy Market Share by Type (2014-2019)
Table Central & South America CAR T-Cell Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Immunotherapy Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in CAR T-Cell Immunotherapy Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table AbbVie Recent Development
Table Celgene Company Details
Table Celgene Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Celgene Recent Development
Table Kite Pharma Company Details
Table Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Kite Pharma Recent Development
Table Oxford BioMedica Company Details
Table Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Oxford BioMedica Recent Development
Table Novartis Company Details
Table Novartis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Novartis Recent Development
Table Gilead Company Details
Table Gilead Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Gilead Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Pfizer Recent Development
Table Cellectis Company Details
Table Cellectis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Cellectis Recent Development
Table Bellicum Company Details
Table Bellicum Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Bellicum Recent Development
Table Mustang Bio Company Details
Table Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2014-2019)(Million US$)
Figure Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2014-2019)
Table Mustang Bio Recent Development
Table CARsgen Therapeutics Company Details
Table Xyphos Company Details
Table Minerva Biotechnologies Company Details
Table Adaptimmune Company Details
Table Ziopharm Oncology Company Details
Table Aurora Biopharma Company Details
Table Creative Biolabs Company Details
Table Global CAR T-Cell Immunotherapy Market Size by Regions (Million US$) 2019-2025
Figure Global CAR T-Cell Immunotherapy Market Size Share by Regions (2019-2025)
Figure Global CAR T-Cell Immunotherapy Market Size Share by Regions in 2025
Figure United States CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure China CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure India CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America CAR T-Cell Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Table Global CAR T-Cell Immunotherapy Market Size by Product (2019-2025) (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size by Product (2019-2025)
Figure Global CAR T-Cell Immunotherapy Market Size by Product in 2025
Table Global CAR T-Cell Immunotherapy Market Size by Application (2019-2025) (Million US$)
Figure Global CAR T-Cell Immunotherapy Market Size by Application (2019-2025)
Figure Global CAR T-Cell Immunotherapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"